Drug Profile
Research programme: zinc finger protein transcription factors - ToolGen
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator ToolGen
- Class
- Mechanism of Action Angiogenesis inducing agents; Angiogenesis inhibitors; Vascular endothelial growth factor A expression inhibitors; Vascular endothelial growth factor A expression stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cancer; HIV infections; Ischaemic heart disorders; Peripheral arterial disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cancer in South Korea (Parenteral, Injection)
- 16 Jul 2016 No recent reports of development identified for preclinical development in HIV-infections in South Korea
- 16 Jul 2016 No recent reports of development identified for preclinical development in Ischaemic-heart-disorders in South Korea